Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Balasch

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 1996
Septate uterus with cervical duplication and longitudinal vaginal septum: a report of three new casesJ Balasch, E Moreno, S Martinez-Román, et al.
Human Reproduction (Oxford, England)|July 1, 1995
The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormoneJ Balasch, F Miró, I Burzaco, et al.
Climacteric : the Journal of the International Menopause Society|December 10, 2013
Long-term effect of hormone therapy on bone in early menopause: vertebral fractures after 20 yearsC Castelo-Branco, J Davila, M F Perelló, et al.
Fertility and Sterility|April 9, 1998
Recurrent in vitro fertilization failure evaluated by fluorescence in situ hybridization: a case reportM Grossmann, J M Calafell, V Moreno, et al.
Human Reproduction (Oxford, England)|June 30, 2000
Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatmentJ Peñarrubia, J Balasch, F Fábregues, et al.
Human Reproduction (Oxford, England)|August 7, 1999
Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)J Balasch, J C Reverter, M Creus, et al.
Human Reproduction (Oxford, England)|June 1, 1995
Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cyclesJ Balasch, F Fábregues, R Tur, et al.
Medicina Clinica|April 23, 1994
[Primary antiphospholipid syndrome: clinical and biological study of 36 cases]J Vivancos, A López-Soto, J Font, et al.
Human Reproduction (Oxford, England)|December 1, 1993
Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndromeJ Balasch, F Carmona, A López-Soto, et al.
Human Reproduction (Oxford, England)|July 1, 1998
Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycleJ Balasch, M Creus, F Fábregues, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 1996
Septate uterus with cervical duplication and longitudinal vaginal septum: a report of three new casesJ Balasch, E Moreno, S Martinez-Román, et al.
Human Reproduction (Oxford, England)|July 1, 1995
The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormoneJ Balasch, F Miró, I Burzaco, et al.
Climacteric : the Journal of the International Menopause Society|December 10, 2013
Long-term effect of hormone therapy on bone in early menopause: vertebral fractures after 20 yearsC Castelo-Branco, J Davila, M F Perelló, et al.
Fertility and Sterility|April 9, 1998
Recurrent in vitro fertilization failure evaluated by fluorescence in situ hybridization: a case reportM Grossmann, J M Calafell, V Moreno, et al.
Human Reproduction (Oxford, England)|June 30, 2000
Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatmentJ Peñarrubia, J Balasch, F Fábregues, et al.
Human Reproduction (Oxford, England)|August 7, 1999
Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)J Balasch, J C Reverter, M Creus, et al.
Human Reproduction (Oxford, England)|June 1, 1995
Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cyclesJ Balasch, F Fábregues, R Tur, et al.
Medicina Clinica|April 23, 1994
[Primary antiphospholipid syndrome: clinical and biological study of 36 cases]J Vivancos, A López-Soto, J Font, et al.
Human Reproduction (Oxford, England)|December 1, 1993
Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndromeJ Balasch, F Carmona, A López-Soto, et al.
Human Reproduction (Oxford, England)|July 1, 1998
Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycleJ Balasch, M Creus, F Fábregues, et al.
Pageof 21